Showing results (1931-1940 of 2,107) with videos related to

Sort By:
Pageof 211
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621Jonathan E Kolitz, Stephen L George, Richard K Dodge, et al.
Leukemia|January 28, 2021
Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic targetFlorencia Palacios, Xiao-Jie Yan, Gerardo Ferrer, et al.
Haematologica|November 8, 2011
Th17 and non-Th17 interleukin-17-expressing cells in chronic lymphocytic leukemia: delineation, distribution, and clinical relevancePreetesh Jain, Mohammad Javdan, Franziska K Feger, et al.
Molecular Medicine (Cambridge, Mass.)|November 15, 2008
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidationRosa Catera, Gregg J Silverman, Katerina Hatzi, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2014
Corticosteroids are associated with repression of adaptive immunity gene programs in pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Geoffrey L Allen, et al.
Cells|April 12, 2022
The Effect of Ex Vivo Human Serum from Liver Disease Patients on Cellular Protein Synthesis and GrowthSophie L Allen, Alex P Seabright, Jonathan I Quinlan, et al.
Critical Care Medicine|August 10, 2020
Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic ShockMihir R Atreya, Brynne E Whitacre, Natalie Z Cvijanovich, et al.
JCI Insight|April 3, 2025
TYRA-300, an FGFR3-selective inhibitor, promotes bone growth in two FGFR3-driven models of chondrodysplasiaJacqueline H Starrett, Clara Lemoine, Matthias Guillo, et al.
The International Journal of Eating Disorders|June 4, 2016
Written case formulations in the treatment of anorexia nervosa: Evidence for therapeutic benefitsKarina L Allen, Caitlin B O'Hara, Savani Bartholdy, et al.
Cancer Research|November 4, 2018
Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal AdenocarcinomaBrittany L Allen-Petersen, Tyler Risom, Zipei Feng, et al.
Pageof 211